Densitas Announces Clinical Advisory Board

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Densitas, a leading provider of AI solutions for digital mammography, announces their advisory board, Drs. Eliot Siegel, Georgia Spear, Nisha Sharma, and Judy Caines.

“We are honored to attract such visionaries to our advisory board,” says Mo Abdolell, CEO of Densitas.  “Their collective expertise spans the fields of radiology, breast imaging, artificial intelligence, and imaging informatics.  Their insights are invaluable as we launch densitas|enterprise™ to tackle the pressing challenges facing breast screening.”

“Computer aided diagnosis/detection for mammography has focused on the very narrow application of a second reader detecting microcalcifications and suspected breast masses and has engendered limited confidence in its practical added value to mammographers,” says Dr. Siegel. “I am intrigued by the broader approach that Densitas’ software suite has taken to not only provide density analysis but also to evaluate overall image quality and provide personalized breast cancer risk assessment. This more comprehensive integration into the overall workflow of image acquisition, image evaluation, and decision support represents the future of AI in a variety of different clinical domains.”

Dr. Siegel, FACR, FSIIM, is widely considered a visionary in radiology and imaging informatics. He is Professor and Vice Chair of Research Information Systems at the University of Maryland School of Medicine and Chief of Radiology and Nuclear Medicine for the VA Maryland Healthcare System. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the world. He has served various leadership positions in academic societies including SPIE, SIIM, ACR, the National Cancer Institute, and RSNA and currently serves as co-chair of the Conference on Machine Intelligence in Medical Imaging. He has written over 200 articles and book chapters about PACS and digital imaging.

Dr. Sharma, MBChB, MRCP, FRCR, MSC, is Director of Breast Screening at Leeds Teaching Hospitals, NHS Trust, United Kingdom. Dr. Sharma has played an integral role in implementing national guidelines on the management of B3 lesions. She is also a panel member on national breast screening committees and a professional clinical advisor to breast screening programs on quality improvement. Her research interests include mammography image quality and risk-based screening based on patient-specific breast cancer risk.

Dr. Spear, MD, MSc, is Chief of Breast Imaging, NorthShore University HealthSystem and Clinical Assistant Professor of Radiology at the University of Chicago Pritzker School of Medicine. Dr. Spear was instrumental in the establishment of the Illinois Breast Density Reporting Law, the first legislation of its kind in the United States. Her research interests focus on supplemental screening with breast ultrasound. Dr. Spear was the recipient of the Susan G. Komen Civic Award in 2018, and serves as an Illinois state representative of the ACR Radiology Advocacy Network.

Dr. Caines, MD, FRCPC, was the founding Medical Director of the Nova Scotia Breast Screening Program (NSBSP), and Head of Mammography, Queen Elizabeth II Health Sciences Centre, Capital District Health Authority, Nova Scotia. Dr. Caines pioneered the stereotactic needle core biopsy procedure in North America and developed a multidisciplinary approach to diagnosis of breast disease.  Her commitment to quality care and service delivery led to the development of an extensive breast imaging electronic medical record that enables the tracking and follow-up of breast imaging procedures province-wide.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.